BriefingIndustry newsIndustry briefingNEWSBiocon Biologics acquires biosimilars business of Viatris for $3bnBiocon subsidiary Biocon Biologics has acquired the international biosimilars business of Viatris in a deal totalling $3bnnewsRegeneron and CytomX partner to develop bispecific cancer therapiesRegeneron has entered a collaboration and licensing agreement with CytomX for developing conditionally-activated bispecific cancer therapiesBriefingUS FDA grants clearance to commence trials of Sorrento’s mRNA vaccineThe US FDA has granted clearance to Sorrento Therapeutics to commence clinical trials of the messenger ribonucleic acid (mRNA) vaccine STI-1557Industry newsIndustry briefing02/23/2024 23:26:12
Briefing
US FDA grants clearance to commence trials of Sorrento’s mRNA vaccine
The US FDA has granted clearance to Sorrento Therapeutics to commence clinical trials of the messenger ribonucleic acid (mRNA) vaccine STI-1557